New weekly shot aims to tame blood sugar and shed pounds in type 2 diabetes
Disease control
Terminated
This study tested whether a weekly injection of CK-0045 could improve blood sugar after meals and reduce body weight in adults with type 2 diabetes and overweight or obesity. About 90 participants received either CK-0045 or a placebo for 16 weeks. The trial was terminated early, …
Phase: PHASE2 • Sponsor: Cytoki Pharma • Aim: Disease control
Last updated May 05, 2026 11:53 UTC